USFDA Approves Aurobindo Pharma’s Cephalexin Tablets 2024: A Key Milestone for the Indian Pharmaceutical Industry
Aurobindo Pharma, a global pharmaceutical company based in India, has received approval…
2024 NCLAT Dismisses Appeals Against Sarda Energy’s SKS IBC Plan: A Detailed Analysis of the Insolvency Case and Its Implications
The National Company Law Appellate Tribunal (NCLAT) recently dismissed appeals challenging Sarda…
2024 Apple Faces Supply Chain Disruption After Tata Plant Fire: Likely to Turn to China for Production Needs
In a Tata Plant Fire significant setback for Apple’s ambitious plans to…
Maruti, Hyundai, Tata Motors Witness Decline in September 2024 Wholesales Amid Inventory Management and Demand Weakness
In September 2024, India's leading automobile manufacturers, including Maruti Suzuki, Hyundai, and…
Factory Manufacturing Growth Activity in India Cooled in September 2024: Analyzing the Slowdown in Manufacturing Growth
In September 2024, Manufacturing Growth India's manufacturing sector experienced a notable cooling…
Centre Picks 3 Monetary Policy New Members for RBI’s Rate-Setting Panel: A Strategic Move for India’s Monetary Policy
The Indian government recently appointed three new external members to the Reserve…
GST Growth Slowed in September: Net Inflows Near ₹1.53 Lakh Crore
The Goods and Services Tax (GST) collections in September 2024 witnessed a…
U.S. FDA Issues 10 Observations to Aurobindo Arm’s API Unit: Navigating Regulatory Compliance in the Pharmaceutical Industry 2024
U.S. FDA Issues the pharmaceutical industry, regulatory compliance plays a crucial role…
SEBI Tightens the Noose on Insider Trading: Strengthening Market Integrity 2024
SEBI Tightens insider trading has long been one of the most significant…
RBI Flags Irregularities in Grant of Gold Loans: Scrutiny of Lenders and Public Criticism 2024
Irregularities in Grant of Gold Loans a recent development that has sent…